Prosecution Insights
Prosecution Insights
19 pending office actions • 6 clients • 18 examiners • 16 art units • 0 of 19 (0%) have an AI response strategy ready • 17 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 9 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 9 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 16 (84%) |
| §102 only | 1 (5%) |
| §112 only | 1 (5%) |
| Double-patenting only | 1 (5%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MCKOY, QUINCY ANDRE | 2 | 70.7% | +38.5% |
| RAGHU, GANAPATHIRAM | 1 | 73.7% | +26.2% |
| LONG, SARAH A | 1 | 60.7% | +42.1% |
| ARMATO JR, DENNIS IGNATIUS | 1 | 47.4% | +76.9% |
| CHEN, PO-CHIH | 1 | 74.2% | +14.5% |
| SPENCER, ANDREA LYNNE MORRIS | 1 | 16.7% | +0.0% |
| KELLY-O'NEILL, YOLANDA LYNNETTE | 1 | 25.0% | +30.8% |
| HOLLAND, PAUL J | 1 | 57.4% | +64.6% |
| BUNKER, AMY M | 1 | 29.1% | +45.8% |
| FRITCHMAN, REBECCA M | 1 | 46.0% | +35.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18033002 | COMPOSITIONS FOR AND METHODS OF CO-ANALYZING CHROMATIN STRUCTURE AND FUNCTION ALONG WITH TRANSCRIPTION OUTPUT | BUNKER, AMY M | 23d overdue |
| 18269622 | COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING GLYCOGEN STORAGE DISEASES | SPENCER, ANDREA LYNNE MORRIS | — |
| 18200156 | Methods and Compositions for the Treatment of Steatosis-Associated Disorders | KELLY-O'NEILL, YOLANDA LYNNETTE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18026088 | METHODS OF DETECTING AND USING BIOMARKERS FOR GLYCOGEN STORAGE DISEASES | FRITCHMAN, REBECCA M | 50d overdue |
| 18473202 | COMPOSITIONS AND METHODS FOR ADJUVANT CANCER THERAPEUTICS | MCKOY, QUINCY ANDRE | 44d overdue |
| 18033002 | COMPOSITIONS FOR AND METHODS OF CO-ANALYZING CHROMATIN STRUCTURE AND FUNCTION ALONG WITH TRANSCRIPTION OUTPUT | BUNKER, AMY M | 23d overdue |
| 18575412 | Compositions For and Methods of Promoting Respiratory Health | ARMATO JR, DENNIS IGNATIUS | 4d overdue |
| 18701982 | COMPOSITIONS AND METHODS RELATING TO EPIGENETIC MODULATION | RAGHU, GANAPATHIRAM | — |
| 18694167 | COMPOSITIONS FOR THE TREATMENT OF FOOD AND CHEMICAL ADDICTION AND METHODS OF MAKING AND USING SAME | MCKOY, QUINCY ANDRE | — |
| 18405331 | COMPOSITIONS COMPRISING A VAGINAL MOLD AND METHODS OF USE THEREOF | LONG, SARAH A | — |
| 18560394 | Compositions For and Methods of Treating and/or Preventing Pain | CHEN, PO-CHIH | — |
| Client (Assignee) | Pending OAs |
|---|---|
| Duke University | 14 |
| U.S. Government | 1 |
| Mayo Clinic | 1 |
| Lurie Children's Hospital | 1 |
| Sanford Burnham Prebys Medical Discovery Inst. | 1 |
| NATIONAL UNIVERSITY OF SINGAPORE | 1 |
| Art Unit | Apps |
|---|---|
| 1631 | 3 |
| 1626 | 2 |
| 1652 | 1 |
| 3771 | 1 |
| 1651 | 1 |
| 1621 | 1 |
| 1692 | 1 |
| 1656 | 1 |
| 1684 | 1 |
| 1758 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18701982 | COMPOSITIONS AND METHODS RELATING TO EPIGENETIC MODULATION | Duke University | RAGHU, GANAPATHIRAM | 1652 | DP | Non-Final OA | — | Pending | Apr 17, 2024 |
| 18694167 | COMPOSITIONS FOR THE TREATMENT OF FOOD AND CHEMICAL ADDICTION AND METHODS OF MAKING AND USING SAME | The United States Department of Health and Human Services | MCKOY, QUINCY ANDRE | 1626 | §112 | Non-Final OA | — | Pending | Mar 21, 2024 |
| 18405331 | COMPOSITIONS COMPRISING A VAGINAL MOLD AND METHODS OF USE THEREOF | Mayo Foundation for Medical Education and Research | LONG, SARAH A | 3771 | §103 | Final Rejection | — | Pending | Jan 05, 2024 |
| 18575412 | Compositions For and Methods of Promoting Respiratory Health | Ann & Robert H. Lurie Children's Hospital of Chicago | ARMATO JR, DENNIS IGNATIUS | 1651 | §103 | Non-Final OA | 4d overdue | Pending | Dec 29, 2023 |
| 18560394 | Compositions For and Methods of Treating and/or Preventing Pain | Sanford Burnham Prebys Medical Discovery Inst. | CHEN, PO-CHIH | 1621 | §103 | Non-Final OA | — | Pending | Nov 12, 2023 |
| 18473202 | COMPOSITIONS AND METHODS FOR ADJUVANT CANCER THERAPEUTICS | Duke University | MCKOY, QUINCY ANDRE | 1626 | §103 | Non-Final OA | 44d overdue | Pending | Sep 22, 2023 |
| 18269622 | COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING GLYCOGEN STORAGE DISEASES | Duke University | SPENCER, ANDREA LYNNE MORRIS | 1631 | §103 | Non-Final OA | — | Pending | Jun 26, 2023 |
| 18200156 | Methods and Compositions for the Treatment of Steatosis-Associated Disorders | National University Of Singapore | KELLY-O'NEILL, YOLANDA LYNNETTE | 1692 | §103 | Final Rejection | — | Pending | May 22, 2023 |
| 18033166 | Compositions and Methods Relating to Alzheimer's Disease | Duke University | HOLLAND, PAUL J | 1656 | §103 | Final Rejection | — | Pending | Apr 21, 2023 |
| 18033002 | COMPOSITIONS FOR AND METHODS OF CO-ANALYZING CHROMATIN STRUCTURE AND FUNCTION ALONG WITH TRANSCRIPTION OUTPUT | Duke University | BUNKER, AMY M | 1684 | §103 | Non-Final OA | 23d overdue | Pending | Apr 20, 2023 |
| 18026088 | METHODS OF DETECTING AND USING BIOMARKERS FOR GLYCOGEN STORAGE DISEASES | Duke University | FRITCHMAN, REBECCA M | 1758 | §103 | Final Rejection | 50d overdue | Pending | Mar 13, 2023 |
| 18024091 | METHODS FOR REPROGRAMMING TARGET CELLS | Duke University | CORDAS, EMILY ANN | 1632 | §103 | Non-Final OA | 27d | Pending | Mar 01, 2023 |
| 17912429 | COMPOSITIONS AND METHODS FOR TREATMENT OF PATHOLOGIC PAIN ASSOCIATED WITH MALIGNANT GROWTH DISORDER | Duke University | MOORE, SUSANNA | 1624 | §103 | Final Rejection | — | Pending | Sep 16, 2022 |
| 17895280 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF MYELIN RELATED AND INFLAMMATION RELATED DISEASES OR DISORDERS | Duke University | JEAN-LOUIS, SAMIRA JM | 1642 | §103 | Final Rejection | 93d overdue | Pending | Aug 25, 2022 |
| 17768152 | LPXH TARGETING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF MAKING AND USING THE SAME | Duke University | CHENG, KAREN | 1623 | §102 | Final Rejection | 31d overdue | Pending | Apr 11, 2022 |
| 17764040 | SYSTEMS AND METHODS FOR LUNG CELL EXPANSION AND DIFFERENTIATION | Duke University | SCHUBERG, LAURA J | 1631 | §103 | Final Rejection | — | Pending | Mar 25, 2022 |
| 17637760 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF PATHOLOGICAL PAIN AND ITCH | Duke University | GRABER, JAMES J | 1631 | §103 | Non-Final OA | 15d | Pending | Feb 23, 2022 |
| 17616499 | COMPOSITIONS AND METHODS FOR BONE REPAIR AND BONE HEALTH | Duke University | NGUYEN, NGOC-ANH THI | 1615 | §103 | Final Rejection | 27d | Pending | Dec 03, 2021 |
| 16477110 | Methods of Treating Brain Injury Using Cord Blood or a Component Thereof | Duke University | WILSON, MICHAEL C | 1638 | §103 | Final Rejection | — | Pending | Jul 10, 2019 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial